Abstract
Abstract: This clinical consensus statement on vaginal energy-based devices (EBDs) reflects an update by content experts from the American Urogynecologic Society's EBD writing group. In 2019, the American Urogynecologic Society's EBD writing group used a modified Delphi process to assess statements that were evaluated for consensus after a structured literature search. A total of 40 statements were assessed and divided into 5 categories: (1) patient criteria, (2) health care provider criteria, (3) efficacy, (4) safety, and (5) treatment considerations. Of the 40 statements that were assessed, 28 reached consensus and the remaining 12 did not. Lack of evidence was among the main reasons that vulvovaginal EBD treatment statements did not reach consensus. In March 2022, these statements were reassessed using the interim literature.
| Original language | English |
|---|---|
| Pages (from-to) | 633-648 |
| Number of pages | 16 |
| Journal | Urogynecology |
| Volume | 28 |
| Issue number | 10 |
| DOIs | |
| State | Published - 1 Oct 2022 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2022 American Urogynecologic Society.
Keywords
- CO 2 laser
- Er:YAG
- dyspareunia
- energy-based devices
- fecal incontinence
- frequency
- laser
- lichen sclerosis
- overactive bladder
- radiofrequency
- stress urinary incontinence
- urgency
- urgency incontinence
- vaginal laxity
- vaginal/vulvovaginal atrophy
- vulvodynia/vestibulitis/vulvar pain sexual dysfunction